These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11826742)

  • 21. [Therapeutic management of acral manifestations of systemic sclerosis].
    Meyer MF; Daigeler A; Lehnhardt M; Steinau HU; Klein HH
    Med Klin (Munich); 2007 Mar; 102(3):209-18. PubMed ID: 17345017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current treatment options in systemic Sclerosis (Scleroderma).
    Stummvoll GH
    Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe cardiac involvement in children with systemic sclerosis and myositis.
    Quartier P; Bonnet D; Fournet JC; Bodemer C; Acar P; Ouachée-Chardin M; Le Bidois J; Prieur AM
    J Rheumatol; 2002 Aug; 29(8):1767-73. PubMed ID: 12180742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of systemic sclerosis.
    Medsger TA
    Rheum Dis Clin North Am; 1989 Aug; 15(3):513-31. PubMed ID: 2672135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term treatments for systemic sclerosis: what are the perspectives?].
    Mouthon L; Agard C; Garcia De La Peña-Lefebvre P; Guillevin L
    Ann Med Interne (Paris); 2002 Jun; 153(4):265-75. PubMed ID: 12218893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of systemic sclerosis].
    van den Hoogen FH
    Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
    Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
    Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular complications of scleroderma.
    Guiducci S; Giacomelli R; Cerinic MM
    Autoimmun Rev; 2007 Sep; 6(8):520-3. PubMed ID: 17854742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine in the treatment of an unusual case of juvenile systemic sclerosis.
    al-Mayouf SM; Silverman ED; Feldman BM; Thorner P; Laxer RM
    J Rheumatol; 1998 Apr; 25(4):791-3. PubMed ID: 9558187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.
    Kowal-Bielecka O; Delcroix M; Vonk-Noordegraaf A; Hoeper MM; Naeije R
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v39-41. PubMed ID: 18784140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of systemic sclerosis. Visions and reality.
    Wollheim FA
    Rheumatology (Oxford); 2005 Oct; 44(10):1212-6. PubMed ID: 15870151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease.
    Valentini G; Paone C; La Montagna G; Chiarolanza I; Menegozzo M; Colutta E; Ruocco L
    Scand J Rheumatol; 2006; 35(1):35-8. PubMed ID: 16467039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of systemic sclerosis.
    Steen VD
    Am J Clin Dermatol; 2001; 2(5):315-25. PubMed ID: 11721650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.
    Nash P; Clegg DO
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii74-7. PubMed ID: 15708943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirect evidence for the efficacy of methotrexate in diffuse systemic sclerosis.
    Low AH; Lee P
    J Rheumatol; 2008 Nov; 35(11):2286. PubMed ID: 19004063
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclophosphamide therapy for scleroderma.
    Akesson A
    Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.